of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
Completed
- Conditions
- Low Density Lipoprotein Cholesterol Goal Achievement
- Registration Number
- NCT00925717
- Lead Sponsor
- AstraZeneca
- Brief Summary
An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4045
Inclusion Criteria
- Subjects who was diagnosed as diabetes
- Subjects who was diagnosed as dyslipidaemia or takes lipid lowering medication
- Clinic visit in the past 6 months more than once
Exclusion Criteria
- Subjects who are unwilling or unable to provide their examination and lab result of medical chart.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Investigate LDL-C goal achievement rate according to ADA recommendation Within the last 6 months from the date of data entry.
- Secondary Outcome Measures
Name Time Method Investigate reduction of 10-year risk for CHD by using UKPDS risk engine Within the last 6 months from the date of data entry.
Trial Locations
- Locations (1)
Research Site
🇰🇷Seoul, Korea, Republic of